NCT07414888

Brief Summary

The purpose of this observational study is to examine whether differences in muscle strength between the dominant and non-dominant sides of the body are associated with sarcopenia in older adults. The study will include adults aged 65 years and older with and without sarcopenia. Muscle strength will be measured on both sides of the body using handgrip strength as well as strength measurements of the biceps (upper arm muscle) and quadriceps (thigh muscle). The difference in strength between the dominant and non-dominant sides will be calculated and compared between participants with sarcopenia and those without sarcopenia. The main question it aims to answers are:

  • Do older adults with sarcopenia have larger differences in muscle strength between the two sides of the body compared with those without sarcopenia?
  • Can differences in arm and leg muscle strength help identify older adults who may be at higher risk of sarcopenia?

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

February 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2026

Completed
Last Updated

March 5, 2026

Status Verified

February 1, 2026

Enrollment Period

17 days

First QC Date

February 11, 2026

Last Update Submit

March 3, 2026

Conditions

Keywords

sarcopeniaMuscle Strength AsymmetryHandgripQuadricepsBicepsDominantNon dominant

Outcome Measures

Primary Outcomes (3)

  • Biceps Muscle Strength Asymmetry

    Difference in biceps muscle strength between the dominant and non-dominant sides measured using Lafayette manual muscle tester.

    Baseline

  • Quadriceps Muscle Strength Asymmetry

    Difference in quadriceps muscle strength between the dominant and non-dominant sides measured using lafayette manual muscle tester.

    Baseline

  • Handgrip Strength (Dominant and Non-Dominant)

    Handgrip strength measured separately for the dominant and non-dominant hands using a hand dynamometer.

    Baseline

Secondary Outcomes (5)

  • Barthel Index of Activities of Daily Living

    Baseline

  • Functional Ambulation Classification (FAC)

    Baseline

  • Body Composition by Bioelectrical Impedance Analysis (BIA)

    Baseline

  • Gait Speed (3 m and 4 m Walk Tests)

    Baseline

  • Short Physical Performance Battery (SPPB)

    Baseline

Study Arms (2)

Sarcopenic Older Adults

Participants aged 65 years and older who meet the diagnostic criteria for sarcopenia according to established guidelines.

Non-Sarcopenic Older Adults

Participants aged 65 years and older who do not meet the diagnostic criteria for sarcopenia.

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will include older adults aged 65 years and older who are evaluated in a hospital or outpatient clinic setting. Participants will be grouped as sarcopenic and non-sarcopenic according to established diagnostic criteria and will undergo standardized assessments of muscle strength, body composition, and physical performance.

You may qualify if:

  • Age 65 years or older
  • Ability to walk independently or with minimal assistance
  • Ability to understand and follow simple instructions
  • Willingness and ability to provide written informed consent
  • Availability of muscle strength measurements (handgrip, biceps, and quadriceps)

You may not qualify if:

  • Lack of cooperation, moderate to severe dementia (e.g., MMSE \<24) or conditions impeding cooperation.
  • Those with severe cardiovascular disease
  • Those with pacemakers
  • Surgical/fracture/acute pain in the measured extremities within the last 6 months.
  • Neurological and muscular disease affecting the upper or lower extremity (acute stroke, severe peripheral neuropathy, etc.)
  • Active systemic disease attack significantly affecting the measurement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Physical Therapy and Rehabilitation Training and Research Hospital

Istanbul, Bahçelievler, 34180, Turkey (Türkiye)

Location

Related Publications (4)

  • Chan OY, van Houwelingen AH, Gussekloo J, Blom JW, den Elzen WP. Comparison of quadriceps strength and handgrip strength in their association with health outcomes in older adults in primary care. Age (Dordr). 2014;36(5):9714. doi: 10.1007/s11357-014-9714-4. Epub 2014 Oct 4.

    PMID: 25280549BACKGROUND
  • Huang S, Chen X, Ding H, Dong B. The relationship between low and asymmetric handgrip strength and low muscle mass: results of a cross-sectional study on health and aging trends in western China. BMC Geriatr. 2024 Aug 2;24(1):650. doi: 10.1186/s12877-024-05199-4.

    PMID: 39095770BACKGROUND
  • Pratt J, Pessanha L, Narici M, Boreham C, De Vito G. Handgrip strength asymmetry as a new biomarker for sarcopenia and individual sarcopenia signatures. Aging Clin Exp Res. 2023 Nov;35(11):2563-2571. doi: 10.1007/s40520-023-02539-z. Epub 2023 Sep 2.

    PMID: 37658983BACKGROUND
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.

    PMID: 20392703BACKGROUND

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • tugba aydın, Associate Professor

    Istanbul Physical Therapy and Rehabilitation Training and Research Hospital

    STUDY DIRECTOR

Central Study Contacts

ugur c onder, Medical Resident

CONTACT

Tugba aydın, Associate Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician

Study Record Dates

First Submitted

February 11, 2026

First Posted

February 17, 2026

Study Start

February 12, 2026

Primary Completion

March 1, 2026

Study Completion

March 12, 2026

Last Updated

March 5, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly shared due to ethical and privacy considerations. Aggregate results will be reported.

Locations